YPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 14.245 EUR -1.35% Market Closed

Market Cap: €41.1B

A	Astellas Pharma Inc XMUN:YPH	JP
M	McDonald's Corp F:MDO	US
D	Daiichi Life Group Inc F:QHH	JP
	Broadcom Inc SIX:AVGO	US
	Prada SpA OTC:PRDSF	IT
	Co-Diagnostics Inc NASDAQ:CODX	US
D	Daiichi Life Group Inc XMUN:QHH	JP
T	Tesla Inc F:TL0	US
F	Fresenius SE & Co KGaA XMUN:FRE	DE

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

10% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

4% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.